Cargando…

The potential combinational immunotherapiesfor treatment of hepatocellular carcinoma

The treatment choices available for hepatocellular carcinoma (HCC) are limited and unsatisfactory. Recent improvements in our understanding of the mechanism involving immune checkpoints, including programmed cell death protein 1 (PD1), programmed death-ligand 1 (PD-L1), and cytotoxic T-lymphocyte-as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Shuai, Bai, Xue, Chen, Shujie, Song, Yang, Liu, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	KeAi Publishing 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562285/ https://www.ncbi.nlm.nih.gov/pubmed/34805871 http://dx.doi.org/10.1016/j.jimed.2019.09.006

Ejemplares similares

Combination treatment including targeted therapy for advanced hepatocellular carcinoma
por: Lin, Jianzhen, et al.
Publicado: (2016)

Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma
por: Shang, Runze, et al.
Publicado: (2021)

Alpelisib combination treatment as novel targeted therapy against hepatocellular carcinoma
por: Xu, Hongwei, et al.
Publicado: (2021)

PHF8 Plays an Oncogene Function in Hepatocellular Carcinoma Formation
por: Ye, Hong, et al.
Publicado: (2019)

PD-L1 combined with HDAC9 is a useful prognostic predictor in hepatocellular carcinoma
por: Yang, Zhao, et al.
Publicado: (2021)

Imaging Diagnosis and Interventional Treatment for Hepatocellular Carcinoma Combined with Arteriovenous Fistula
por: Cai, Zheng, et al.
Publicado: (2021)

Adjuvant therapies after curative treatments for hepatocellular carcinoma: Current status and prospects
por: Zhu, Xiao-Dong, et al.
Publicado: (2020)

Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination
por: Ju, Shuguang, et al.
Publicado: (2022)

Recent Update on Immunotherapy and Its Combination With Interventional Therapies for Hepatocellular Carcinoma
por: Huang, Jin-Tao, et al.
Publicado: (2022)

Combined Hyperthermia and Radiation Therapy for Treatment of Hepatocellular Carcinoma
por: Talaat, Roba M, et al.
Publicado: (2019)

Synergistic Antitumor Effect of Sorafenib in Combination with ATM Inhibitor in Hepatocellular Carcinoma Cells
por: Liu, Jianhua, et al.
Publicado: (2017)

Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis
por: Li, Kang-Shuai, et al.
Publicado: (2022)

The fusion landscape of hepatocellular carcinoma
por: Zhu, Chengpei, et al.
Publicado: (2019)

Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
por: SHAO, WENBO, et al.
Publicado: (2014)

Quantitative Assessment of Hypovascular Component in Arterial Phase to Help the Discrimination of Combined Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma
por: Yang, Xue, et al.
Publicado: (2023)

Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma
por: Liu, Xianqiong, et al.
Publicado: (2019)

Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma
por: Zhou, Qunfang, et al.
Publicado: (2020)

The combination of Biochanin A and SB590885 potentiates the inhibition of tumour progression in hepatocellular carcinoma
por: Xiao, Yi, et al.
Publicado: (2020)

Assessment of the feasibility of TACE combined with intratumoral injection of cisplatin in hepatocellular carcinoma
por: Zhaomin, Song, et al.
Publicado: (2015)

Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Identification of the Mechanism of Matrine Combined with Glycyrrhizin for Hepatocellular Carcinoma Treatment through Network Pharmacology and Bioinformatics Analysis
por: Han, Tao, et al.
Publicado: (2022)

Combination of Peglated-H1/HGFK1 Nanoparticles and TAE in the Treatment of Hepatocellular Carcinoma
por: Gao, Dazhi, et al.
Publicado: (2022)

Radiofrequency ablation combined with transarterial chemoembolization in treatment of hepatocellular carcinoma adjacent to the second hepatic hilus
por: Chen, Meng-Li, et al.
Publicado: (2021)

Current status and prospect of treatments for recurrent hepatocellular carcinoma
por: Yang, Yu-Qing, et al.
Publicado: (2023)

Prognostic potential of PRPF3 in hepatocellular carcinoma
por: Liu, Yinlan, et al.
Publicado: (2020)

Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma
por: Liu, Furong, et al.
Publicado: (2019)

The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome
por: Zheng, Bo‐Hao, et al.
Publicado: (2020)

Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapies
por: Roderburg, Christoph, et al.
Publicado: (2020)

Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?
por: Sparchez, Zeno, et al.
Publicado: (2021)

Value of ultrasound combined with MRI in the diagnosis of primary and recurrent hepatocellular carcinoma
por: Ji, Xiaoli, et al.
Publicado: (2019)

Combination of Permanent Interstitial (125)I-Seed Brachytherapy and Surgery for the Treatment of Large Hepatocellular Carcinoma
por: Li, Xiaogang, et al.
Publicado: (2017)

Comparison of Imaging and Clinically Relevant Features of Combined Hepatocellular Carcinoma and Cholangiocarcinoma with Hepatocellular Carcinoma
por: Huang, Xialing, et al.
Publicado: (2019)

Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma
por: Li, Lanqing, et al.
Publicado: (2022)

Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma
por: Yang, Heng, et al.
Publicado: (2021)

LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway
por: Zhang, Quan, et al.
Publicado: (2020)

Advanced Hepatocellular Carcinoma With Hepatic Arterioportal Shunts: Combination Treatment of Transarterial Chemoembolization With Apatinib
por: Sun, Tao, et al.
Publicado: (2020)

Comparison of Efficacy and Safety of TACE Combined with Microwave Ablation and TACE Combined with Cryoablation in the Treatment of Large Hepatocellular Carcinoma
por: Wang, Yujia, et al.
Publicado: (2022)

Transarterial chemoembolization combined with radiofrequency ablation in the treatment of large hepatocellular carcinoma with stage C
por: Sun, Sha-Sha, et al.
Publicado: (2022)

The Role of ANGPTL Gene Family Members in Hepatocellular Carcinoma
por: Bai, Yun, et al.
Publicado: (2022)

Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma
por: Kim, Dong-Hyun
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tpgp07puchibbkpbc9f0gt5lfe